Paragon Genomics is a biotechnology company that specializes in providing next-generation sequencing (NGS) solutions. Founded in 2015, the company focuses on developing and delivering highly efficient and targeted NGS panels, enabling researchers and clinicians to conduct precise genomic analysis. Their proprietary CleanPlex® technology offers custom and pre-designed panels for a variety of applications, including oncology, inherited diseases, and infectious disease testing. Paragon Genomics is committed to advancing genomic research with flexible, high-performance, and cost-effective tools that enhance data quality and reduce workflow complexity.